蛋白质纯化与分离市场－全球产业规模、份额、趋势、机会及预测（依应用、产品、技术、地区及竞争格局划分，2021-2031年）

全球蛋白质纯化和分离市场预计将从 2025 年的 91.7 亿美元成长到 2031 年的 161.8 亿美元，复合年增长率为 9.93%。

该领域涵盖电泳和层析法等关键技术，用于从复杂混合物中提取特定蛋白质，以用于治疗和研究目的。市场的主要驱动力是需要生物疗法的慢性疾病发生率不断上升，以及生物製药生产能力的相应增长。这些因素持续推动对纯化技术的需求，以确保原料药的安全性和纯度，从而成为推动产业成长的核心动力，即使市场存在暂时性波动。

市场扩张的主要障碍之一是先进纯化设备所需的大量初始投资，这限制了小规模研究机构获得此类设备的机会。该行业的高财务风险也反映在推动采购需求的区域投资趋势中。根据欧洲製药工业协会联合会 (EFPIA) 的报告，欧洲製药业计划在 2024 年投入约 550 亿欧元用于研发，凸显了该领域投入的大量资源。

市场驱动因素

生物製药和生物製药市场的扩张是推动该产业发展的关键因素。随着製药开发商日益重视生物疗法，他们越来越依赖下游製程来满足严格的纯度要求。根据美国食品药物管理局(FDA) 于 2024 年 1 月发布的《2023 年新药核准情况报告》，已有 55 种新分子实体 (NME) 获得核准，这凸显了治疗创新步伐的加快，而这需要强大的分离通讯协定。生物製药核准的增加与层析管柱和纯化树脂采购量的成长直接相关。例如，赛默飞世尔科技 (Thermo Fisher Scientific) 在 2024 年 1 月发布的 2023 财年财报中公布的 428.6 亿美元年收入，就体现了支持基础设施的规模之大，也展现了生命科学服务和工具市场的巨大潜力。

此外，生命科学领域研发投入的增加推动了产业成长，使实验室能够购买先进设备。持续的资金投入有助于抵消自动化纯化系统的高成本，使实验室能够更新工作流程并采用高通量技术。这笔资金对于缩短药物研发週期和提高营运效率至关重要。根据美国药品研究与製造商协会 (PhRMA) 于 2024 年 8 月发布的《2024 年 PhRMA 会员调查报告》，预计会员公司在 2023 年的研发支出将达到 1,035 亿美元。这项巨额投资确保了对分离生物标记和治疗性蛋白质所需的资本设备和耗材的持续需求。

市场挑战

全球蛋白质纯化和分离市场的一大障碍是先进纯化设备所需的高昂初始投资成本。这一经济壁垒限制了小规模的研究中心、学术机构和新兴生物技术公司的进入，因为它们不像大型製药公司那样财力雄厚。由于这些小规模机构对科学进步和早期药物发现至关重要，它们无法获得必要的纯化系统会阻碍研究进展，并降低整个产业的设备普及率。

近期产业资金筹措的波动加剧了这些资金限制的影响，严重削弱了小规模企业的购买力。根据生技创新局的数据，到2025年，生技Start-Ups的资金筹措从第一季的26亿美元骤降至第二季的9亿美元。可用资金的减少迫使新兴企业推迟或放弃对关键分离技术的投资。因此，这些关键终端用户的资金短缺造成了需求瓶颈，儘管科学界对这些仪器有着明确的需求，但市场成长却因此放缓。

市场趋势

一次性净化技术的广泛应用正在变革生产流程，它无需进行复杂的清洁验证，并降低了交叉污染的风险。越来越多的合约研发生产机构（CDMO）正从传统的不銹钢设备转向灵活的一次性系统，以管理多样化的生物产品线，这一趋势尤其明显。这种转变使工厂能够更快地切换产品线，提高产能运转率并降低用水量。例如，无锡生物製药在2024年6月的新闻稿中宣布，将在其杭州工厂安装三台新的5000公升一次性生物反应器，将其总产能从8000公升扩大到23000公升，以满足全球需求，这体现了其对可扩展一次性基础设施的承诺。

同时，人工智慧在製程优化的应用正在变革纯化通讯协定的设计与执行。透过利用先进的机器学习演算法，製造商可以预测理想的层析法和过滤设置，从而显着减少製程开发所需的实验工作量。这种数位化变革实现了分离单元的即时监控和自适应控制，确保产品品质的稳定性并降低产量损失。随着企业寻求改善营运并做出数据驱动的决策，整个产业向这些数位化工具的转型正在加速。根据Benchling于2024年11月发布的《2024年生物製药技术趋势报告》，67%的领先生物製药公司正在采用人工智慧和机器学习来增强其研发能力。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章：全球蛋白质纯化与分离市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依应用领域（药物筛检、生物标记发现、蛋白质-蛋白质交互作用研究、诊断）
  • 依产品分类（设备、耗材）
  • 透过技术（超过滤、沉淀、层析法、电泳、蛋白质印迹等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美蛋白质纯化与分离市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲蛋白质纯化与分离市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区蛋白质纯化与分离市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲蛋白质纯化分离市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲蛋白质纯化与分离市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球蛋白质纯化与分离市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN NV
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• GE HealthCare Technologies Inc.
• Promega Corporation
• Norgen Biotek Corp.
• Abcam Limited
• Danaher Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Protein Purification and Isolation Market is projected to expand from USD 9.17 Billion in 2025 to USD 16.18 Billion by 2031, reflecting a CAGR of 9.93%. This sector encompasses critical techniques such as electrophoresis and chromatography, which are utilized to extract specific proteins from complex mixtures for therapeutic and research purposes. The market is largely driven by the rising incidence of chronic diseases necessitating biologic treatments and the associated growth in biopharmaceutical manufacturing capabilities. These factors generate a persistent need for purification technologies to guarantee the safety and purity of drug substances, serving as the core engine for industry growth regardless of transient market shifts.

One major obstacle to market expansion is the substantial initial capital investment required for sophisticated purification instruments, which limits availability for smaller research entities. The high financial stakes of the industry are mirrored in regional investment trends that fuel these procurement demands. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector in Europe allocated approximately €55,000 million toward research and development in 2024, highlighting the significant resources directed into this field.

Market Driver

The expansion of the biopharmaceutical sector and the biologics market acts as a major catalyst for this industry. As pharmaceutical developers increasingly prioritize biological therapies, the reliance on downstream processing grows to satisfy rigorous purity requirements. Data from the U.S. Food and Drug Administration's 'Novel Drug Approvals for 2023' report in January 2024 indicates the approval of 55 new molecular entities, underscoring the quickening rate of therapeutic innovation that demands strong isolation protocols. This increase in biologic approvals is directly linked to higher purchases of chromatography columns and purification resins. Demonstrating the magnitude of the supporting infrastructure, Thermo Fisher Scientific reported in their January 2024 press release regarding full-year 2023 results that they achieved $42.86 billion in annual revenue, indicating the substantial volume of the market for life sciences services and tools.

Furthermore, rising investment in life sciences research and development drives growth by allowing laboratories to purchase advanced equipment. Continuous funding helps offset the high expense of automated purification systems, enabling facilities to update their workflows and adopt high-throughput technologies. This capital flow is crucial for shortening drug development schedules and improving operational efficiency. As noted by the Pharmaceutical Research and Manufacturers of America in their '2024 PhRMA Annual Membership Survey' published in August 2024, member firms spent $103.5 billion on R&D in 2023. This massive financial commitment guarantees ongoing demand for the capital equipment and consumables needed to isolate biomarkers and therapeutic proteins.

Market Challenge

A major obstacle hindering the Global Protein Purification and Isolation Market is the substantial upfront capital cost needed for sophisticated purification instruments. This financial barrier limits entry for smaller research centers, academic bodies, and startup biotechnology companies, which typically do not possess the extensive funds available to large pharmaceutical enterprises. Because these smaller organizations are vital for scientific advancement and early drug discovery, their inability to acquire necessary purification systems hampers research progress and decreases the overall rate of equipment adoption within the sector.

The impact of these financial limitations is exacerbated by recent volatility in sector funding, which severely restricts the buying power of smaller players. Data from the Biotechnology Innovation Organization indicates that in 2025, funding for biotech startups fell from $2.6 billion in the first quarter to just $900 million in the second. This reduction in available capital forces emerging firms to postpone or abandon investments in essential isolation technologies. As a result, the lack of liquidity among these crucial end-users causes a demand bottleneck, slowing market growth despite the clear scientific need for these instruments.

Market Trends

The extensive uptake of single-use purification technologies is transforming manufacturing processes by removing the necessity for intricate cleaning validation and lowering cross-contamination risks. This trend is notably visible in the expansion of contract development and manufacturing organizations, which are progressively substituting traditional stainless-steel setups with flexible disposable systems to manage varied biologic pipelines. This shift enables facilities to transition between product lines more quickly, enhancing capacity usage and decreasing water consumption. Highlighting this dedication to scalable disposable infrastructure, WuXi Biologics announced in a June 2024 press release the installation of three new sets of 5,000-liter single-use bioreactors at its Hangzhou site, boosting total capacity from 8,000 to 23,000 liters to satisfy global needs.

Simultaneously, the incorporation of artificial intelligence into process optimization is changing the design and execution of purification protocols. Utilizing sophisticated machine learning algorithms allows manufacturers to forecast ideal chromatography conditions and filtration settings, greatly lessening the experimental load needed for process development. This digital evolution permits real-time monitoring and adaptive management of isolation units, guaranteeing consistent product quality and reducing yield waste. The sector's move towards these digital tools is gaining speed as firms aim to improve operations and data-based decision-making. As reported by Benchling in their '2024 State of Tech in Biopharma Report' from November 2024, 67% of major biopharmaceutical companies have embraced artificial intelligence and machine learning to upgrade their R&D capabilities.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• QIAGEN N.V
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• GE HealthCare Technologies Inc.
• Promega Corporation
• Norgen Biotek Corp.
• Abcam Limited
• Danaher Corporation

Report Scope

In this report, the Global Protein Purification and Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Purification and Isolation Market, By Application

• Drug Screening
• Biomarker Discovery
• Protein-Protein
• Interaction Studies
• Diagnostics

Protein Purification and Isolation Market, By Product

• Instruments
• Consumables

Protein Purification and Isolation Market, By Technology

• Ultrafiltration
• Precipitation
• Chromatography
• Electrophoresis
• Western Blotting
• Others

Protein Purification and Isolation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Purification and Isolation Market.

Available Customizations:

Global Protein Purification and Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Purification and Isolation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Drug Screening, Biomarker Discovery, Protein-Protein, Interaction Studies, Diagnostics)
  • 5.2.2. By Product (Instruments, Consumables)
  • 5.2.3. By Technology (Ultrafiltration, Precipitation, Chromatography, Electrophoresis, Western Blotting, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Protein Purification and Isolation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Purification and Isolation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
  • 6.3.2. Canada Protein Purification and Isolation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
  • 6.3.3. Mexico Protein Purification and Isolation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology

7. Europe Protein Purification and Isolation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Purification and Isolation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
  • 7.3.2. France Protein Purification and Isolation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
  • 7.3.3. United Kingdom Protein Purification and Isolation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
  • 7.3.4. Italy Protein Purification and Isolation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
  • 7.3.5. Spain Protein Purification and Isolation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology

8. Asia Pacific Protein Purification and Isolation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Purification and Isolation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
  • 8.3.2. India Protein Purification and Isolation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
  • 8.3.3. Japan Protein Purification and Isolation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology
  • 8.3.4. South Korea Protein Purification and Isolation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technology
  • 8.3.5. Australia Protein Purification and Isolation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technology

9. Middle East & Africa Protein Purification and Isolation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Purification and Isolation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
  • 9.3.2. UAE Protein Purification and Isolation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
  • 9.3.3. South Africa Protein Purification and Isolation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology

10. South America Protein Purification and Isolation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Purification and Isolation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
  • 10.3.2. Colombia Protein Purification and Isolation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
  • 10.3.3. Argentina Protein Purification and Isolation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Purification and Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck KGaA
• 15.3. QIAGEN N.V
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. Agilent Technologies, Inc.
• 15.6. GE HealthCare Technologies Inc.
• 15.7. Promega Corporation
• 15.8. Norgen Biotek Corp.
• 15.9. Abcam Limited
• 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer